4 reported observational data from Shanghai Sixth Peoples Hospital, China, showing that, with adequate treatment duration, GLP-1 agonists may have disease-modifying effects in patients with KOA with comorbid Type 2 diabetes, potentially mediated by weight loss
Any effects discussed are based on research and user reports
By activating GLP-1 receptors in the brain, GLP-1 shots reduces the urge to eat and promotes weight loss
Spending a few minutes comparing two or three options upfront can save you hundreds over a full treatment course
From Zagreb to Longevity Clinics In my last edition, I covered BPC-157, the first peptide I ever learned about back in the 1990s while studying pharmacy in the former Yugoslavia
Cleaning the injection site with an alcohol swab is standard practice